A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in ...
Despite several randomized controlled trials demonstrating the benefits of combination therapies for metastatic hormone-sensitive prostate cancer (mHSPC), a significant treatment gap persists. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results